RT Journal Article
SR Electronic
T1 Low COVID-19 mortality in old age homes in western India: an empirical study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.08.20245134
DO 10.1101/2020.12.08.20245134
A1 Jallavi Panchamia
A1 Bhavya Bhagat
A1 Vishakha Bharati
A1 Anushree Joshi
A1 Dileep Mavalankar
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.12.08.20245134.abstract
AB Objective The study intended to understand the effect of Coronavirus disease 2019 (COVID-19) on western Indian elderly care homes. The study aimed to know the actions taken by administration of homes and challenges faced during the lockdown period.Method Total 44 care homes across three states of western India were contacted for data collection during the period of September-November 2020. Structured interview of the manager or owner of the elderly care homes were taken to gather required information to achieve the study objectives.Results Out of 44 care homes, seven care homes reported 146 case of corona virus infection and four deaths. Hence, the reported covid cases rate found to be 928 per 10,000 residents.Discussion Results of the study indicated that significant steps were taken by these old age care homes to stave off the infection spread among the inmates. It was observed that average 26% of the occupants were sent back to their home/relative’s home before the lockdown to decongest the care homes. Administrators adopted the new policies at care home and adhered the government guidelines. Care homes in western India seemed to have very low infection rate and very low number of deaths as compared to western world.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval from ethics committee of the institute was taken before conducting the study. Following are the IEC(Institute Ethics committee) body that provided the approval. 1.Institute Ethics Committee Chair: Dr. V. R. S. Cowlagi (I.A.S. (Retd.) Vigilance commissioner, Gandhinagar). 2.Member Secretary: Dr. Komal Shah, (Assistant Professor, Indian institute of Public health, Gandhinagar) 3.External member of the committee: Dr. Parvati Iyer, (Associate Professor, Central university of Gujarat, Gandhinagar) 4.External member of the committee: Dr. Rashmi Sharma, Faculty-PSM, GEMRS Medical college, Gujarat 5.Committee member: Dr. Mahaveer Golecha (Associate Professor, Indian institute of Public health, Gandhinagar) 6.Committee member: Dr. Somen Saha (Associate Professor, Indian institute of Public health, Gandhinagar) Decision made: Ethical Approval was given and approval letter is sent to the editor of this journal board. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata will be available on request.